Image

Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain

Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

This study aims to compare the frequency of occurrence of ipsilateral shoulder pain in patients undergoing thoracotomy with ultrasound-guided interscalene block, anterior suprascapular block as adjunct to epidural and epidural block only.

Description

Thoracotomy is one type of surgery associated with challenging pain that needs to be promptly addressed to avoid post-operative respiratory complications and aid in effective postoperative physiotherapy and patient recovery. Epidural analgesia is considered the gold standard for the thoracotomy procedure. Ipsilateral shoulder pain (ISP) following thoracotomy has an incidence ranging from 37% to 85%.

Being so common, this pain needs more attention and proper anticipation, and management. ISP is usually non-responsive to the effects of epidural and paravertebral blocks.

Eligibility

Inclusion Criteria:

  • Age \> 18 years and ≤ 65 years old.
  • American Society of Anesthesiologists (ASA) physical status II-III.
  • Body mass index 18-35 kg/m2.
  • Patients who have a confirmed diagnosis of lung cancer and are scheduled for elective open-lung surgery.

Exclusion Criteria:

  • Allergy to local anesthetics.
  • Known psychiatric or neurologic disorders.
  • Alcohol or narcotics abuse.
  • Contraindications to thoracic epidural or suprascapular block, or interscalene block, e.g., coagulopathy or local infection.
  • Pre-existing shoulder symptoms.
  • History of previous thoracotomy.
  • Severe restrictive or obstructive pulmonary disease.
  • Pre-existing contralateral diaphragmatic paralysis.

Study details
    Interscalene Block
    Anterior Suprascapular Block
    Thoracotomy
    Shoulder Pain

NCT07424638

National Cancer Institute, Egypt

26 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.